EMA: Q&As on the Topic of "Parallel Distribution" updated
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
Again, the "Frequently asked questions about parallel distribution" were revised and published on the EMA website. The information provided by the EMA on parallel distribution of centrally authorised medicinal products is set out in the Q&A in six paragraphs:
- General
- Initial notification
- Parallel distribution notification check
- Post - Parallel distribution notice guidance
- Safety updates/bulk changes/annual update
- Fees
In the latest version, the following question has been added to the first section "General":
- 07. What to do when my organisation details have changed?
In the fifth paragraph "Safety updates/bulk changes/annual update", questions 4 and 5 and their answers have been updated:
- 04. How to submit a bulk change?
- 05. What is an annual update?
The four other sections remain unchanged.
The updates and the complete list of answers to the "Frequently asked questions about parallel distribution" can be found on the EMA website.
Related GMP News
21.10.2026EMA Clarifies ESMP Reporting for Critical Medicine Shortages
20.10.2026EDQM Updates Guidance on CEP Sister File Applications
20.10.2026EDQM Revises Guidance on Electronic Submissions for CEP Applications
14.10.2026Bioassays in the United States Pharmacopoeia - Two Chapters come into Force in Spring
07.10.2026CEP 2.0: EDQM Updates Guidance on the Use of Certificates of Suitability
23.09.2026IRIS Portal: EMA expands digital Procedure Management